NfL

There are 1,065 papers on NfL in aging research: 61 trials and 873 observational studies in people, 30 in animals, 87 reviews. The newest story, Nov 5, 2026: “Blood marker may link depressive symptoms to cognitive decline”.

Biomarker

1,065 papers study it715 findings

32 new papers in 30 daysSee all 1,065 papers on NfL

“changes in NfL, which were correlated with changes in kidney function associated with intensive treatment.”
Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)Alzheimer's & dementia : the journal of the Alzheimer's Association2021doi:10.1002/alz.12496
  • Human trial61
  • Humans873
  • Animals30
  • In silico5

Interventions

56

Hearing aids

downin humans2no changein humans1

3 studies
  1. Hearing aids showed no clear effect on NfL in humans (difference: −0.159; 95% CI: −0.348, 0.029).

    “A comparable effect was observed for NfL (intervention: 0.171; 95% CI: 0.022, 0.319, control: 0.330; 95% CI: 0.185, 0.475, difference: −0.159; 95% CI: −0.348, 0.029; p-difference: 0.098), although the difference was not statistically significant.”

    Human trial3 yearsn = 164

    Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

    EClinicalMedicine

  2. Hearing aids showed no clear effect on NfL in humans (untreated hearing loss without substantial cognitive impairment) (difference: -0.159; 95 %CI: -0.348, 0.029).

    “NfL (intervention: 0.171; 95% CI: 0.022, 0.319, control: 0.330; 95 %CI: 0.185, 0.475, difference: -0.159; 95 %CI: -0.348, 0.029; p-difference: 0.098)”

    Human trialuntreated hearing loss without substantial cognitive impairmentplasma3 yearsn = 164

    Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

    EClinicalMedicine

  3. Hearing aids decrease NfL in ARIC participants with untreated hearing loss (mean -0.349 (95% CI -0.652, -0.046)).

    “Among ARIC participants, intervention resulted in lower 3-year GFAP(mean:-0.415;95%CI:-0.712,-0.118) and NfL(mean:-0.349;95%CI:-0.652,-0.046).”

    Human trialin ARIC participants with untreated hearing loss3 yearsn = 164

    Effects on Blood Neurodegeneration Biomarkers of a Randomized Hearing Rehabilitation Intervention

    GSA 2025 abstract

  4. Hearing aids decrease NfL in humans.

    “After six months of hearing aid use, we re-evaluated the MMSE and SRT scores and serum biomarkers levels in the ARHL group: we recorded significant improvements both in cognitive and word recognition tests and in biomarker values.”

    Human trialn = 30

    Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss

    Journal of clinical medicine

More on Hearing aids

Physical activity

downin humans2no changein humans1

3 studies
  1. Physical activity is linked with lower NfL in humans (B = -0.10, 95% CI: -0.17 to -0.03).

    “Age 56 MET hours were inversely associated with NfL and GFAP at 67 (NfL: B = -0.10, 95% confidence interval [CI]: -0.17 to -0.03”

    Humansmales

    Midlife activity linked to lower brain-related markers in men

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. Physical activity is linked with lower NfL in amyloid-negative group (estimate -2.030 × 10−4, p = 0.014).

    “In amyloid-negative group, average PASE was associated with a slower increase of serum neurofilament light chain”

    Humansin amyloid-negative groupserum

    Amyloid status as a moderator of the association between physical activity and progression of Parkinson's disease

    Parkinsonism & related disorders

  3. Physical activity was not clearly linked with NfL in humans.

    “There was no relationship between physical activity and p ‐tau 181 or NfL.”

    Humans

    Physical activity and blood‐based biomarkers of neurodegeneration in community dwelling Australians from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease)

    AAIC 2025 abstract

More on Physical activity

Aerobic exercise

no changein humans1downin humans1

2 studies
  1. Aerobic exercise decreases NfL in humans (NFL decreased 32%; GFAP decreased 10%).

    “NFL and GFAP levels were statistically lower in the study group at the end of the study than before the study.”

    Human trialRelapsing-remitting multiple sclerosis; aerobic exercise plus home exercises, compared with baselineserum3 times per week at 60–70% of maximal aerobic capacity8 weeks

    The effect of aerobic exercise on Neurofilament light chain and glial Fibrillary acidic protein level in patients with relapsing remitting type multiple sclerosis

    Multiple sclerosis and related disorders

  2. Aerobic exercise showed no clear effect on NfL in humans (AD, VCI, HD, or MS).

    “Conversely, prolonged moderate-to-high intensity aerobic exercise yielded no significant effects on NfL in AD, VCI, HD, or MS.”

    ReviewAD, VCI, HD, or MSmoderate-to-high intensityprolonged

    Effects of physical exercise on neurofilament light chain in multiple sclerosis and other neurological disorders: A systematic review

    Multiple sclerosis and related disorders

More on Aerobic exercise

Vitamin K

downin humans2

2 studies
  1. Vitamin K is linked with lower NfL in humans (third vitamin K intake tertile vs first tertile) (β = -0.16 [95% confidence interval -0.29 to -0.02]; p = 0.023).

    “Individuals in the third vitamin K intake tertile exhibited lower serum NfL levels than those in the first tertile (regression coefficient, β = -0.16 [95% confidence interval -0.29 to -0.02]; p = 0.023).”

    Humansthird vitamin K intake tertile vs first tertile

    Individual and combined effects of dietary vitamin intake on cognitive function in elderly adults: the potential mediating role of serum neurofilament light chain levels

    Frontiers in nutrition

  2. Vitamin K is linked with lower NfL in humans (Q4 vs. Q1, β = -4.92, 95%CI: -7.66, -2.19, p = 0.002).

    “individuals with higher dietary vitamin K intake had lower serum NfL levels (Q4 vs. Q1, β = -4.92, 95%CI: -7.66, -2.19, p = 0.002).”

    Humansn = 1,533

    Dietary vitamin K intake is associated with decreased neurofilament light chain among middle-aged and older adults from the NHANES

    Frontiers in nutrition

More on Vitamin K

Cholecalciferol

downin humans1

1 study
  1. Cholecalciferol decreases NfL in humans Among Black participants (-16.2% (95% CI: −30.5% to 1.1%)).

    “Among Black participants, there was a mean 16.2% reduction in NfL levels (95% CI: −30.5% to 1.1%; p‐interaction = 0.06; Table ) comparing the vitamin D3 and placebo groups”

    Human trialAmong Black participants4‐year

    Effects of long-term daily supplementation with vitamin D3 and marine omega-3 fatty acids on change in ADRD biomarkers: A secondary analysis of a randomized clinical trial

    Alzheimer's & dementia (New York, N. Y.)

  2. Cholecalciferol decreases NfL in Black participants (-16.2% (95% CI: -30.5% to 1.1%)).

    “vitamin D3 supplementation resulted in a 16.2% reduction in NfL levels [95% CI: -30.5% to 1.1%; p-interaction = 0.06]”

    Human trialin Black participantsplasma2000 IU/day4 years

    Effects of long-term daily supplementation with vitamin D3 and marine omega-3 fatty acids on change in ADRD biomarkers: A secondary analysis of a randomized clinical trial

    Alzheimer's & dementia (New York, N. Y.)

More on Cholecalciferol

Endurance exercise

upin rats1downin rats1

1 study
  1. Endurance exercise increases NfL in rats (Wistar Kyoto rats) (2.9-fold increase).

    “In WKY rats, exercise paradoxically led to a modest yet significant increase in NfL (2.9-fold, p < 0.001).”

    AnimalsWistar Kyoto ratsmoderate-intensity treadmill trainingplasma30 min/day, 5 days/week

    Endurance Exercise Attenuates Plasma Level of Neurofilament Light Chain and Prevents Body Weight Loss in a Rat Model of Tauopathy

    Physiological research

  2. Endurance exercise decreases NfL in rats (WKY72 rat model of tauopathy) (3.8-fold increase in trained animals versus 8.9-fold increase in sedentary animals).

    “moderate-intensity endurance exercise attenuates plasma level of NfL in tauopathic rats”

    AnimalsWKY72 rat model of tauopathymoderate-intensity treadmill trainingplasma30 min/day, 5 days/week

    Endurance Exercise Attenuates Plasma Level of Neurofilament Light Chain and Prevents Body Weight Loss in a Rat Model of Tauopathy

    Physiological research

More on Endurance exercise

Mindfulness

no changein humans1−3%

1 study
  1. Mindfulness showed no clear effect on NfL in humans within-arm from baseline to follow-up (V1 to V3) (-3.0%).

    “Within the CMBAS arm, there was no significant change in log NfL from V1 to V2 (estimated change [95 % confidence interval]: −0.05 [−0.12 to 0.02]), or V1 to V3 (−0.03 [−0.10 to 0.04]).”

    Human trialwithin-arm from baseline to follow-up (V1 to V3)8-week arms and a 6-month follow-up

    Can non-pharmacological interventions change levels of neurofilament light in older adults at risk of dementia? A secondary analysis of the SCD-Well randomized clinical trial

    The journal of prevention of Alzheimer's disease

  2. Mindfulness showed no clear effect on NfL in humans (subjective cognitive decline).

    “no significant changes in NfL were observed within the CMBAS or HSMP arms from V1 to V2.”

    Human trialsubjective cognitive declineplasma8 weeksn = 119

    Can non-pharmacological interventions change levels of neurofilament light in older adults at risk of dementia? A secondary analysis of the SCD-Well randomized clinical trial

    The journal of prevention of Alzheimer's disease

More on Mindfulness

Health self-management program

downin humans1

1 study
  1. Health self-management program decreases NfL in humans within-arm from baseline to follow-up (V1 to V3).

    “However, from V1 to V3 there was a significant reduction in log NfL (−0.10 [−0.18 to −0.02]).”

    Human trialwithin-arm from baseline to follow-up (V1 to V3)8-week arms and a 6-month follow-up

    Can non-pharmacological interventions change levels of neurofilament light in older adults at risk of dementia? A secondary analysis of the SCD-Well randomized clinical trial

    The journal of prevention of Alzheimer's disease

  2. Health self-management program decreases NfL in humans (subjective cognitive decline) (-0.10, 95 % CI [-0.18 to -0.02]).

    “within the HSMP arm, NfL levels reduced from V1 to V3 (-0.10, 95 % confidence interval [-0.18 to -0.02]).”

    Human trialsubjective cognitive declineplasma6-month follow-upn = 115

    Can non-pharmacological interventions change levels of neurofilament light in older adults at risk of dementia? A secondary analysis of the SCD-Well randomized clinical trial

    The journal of prevention of Alzheimer's disease

More on Health self-management program

Fenofibrate

downin humans1

1 study
  1. Fenofibrate decreases NfL in older adult patients with cTBI.

    “fenofibrate treatment reduced plasma neurofilament light chain levels and improved cognitive functions.”

    Human trialin older adult patients with cTBIn = 40

    Fenofibrate improves cognition in chronic brain injury trial

    Science translational medicine

More on Fenofibrate

Choline

downin humans1

1 study
  1. Choline decreases NfL in humans.

    “CSF NfL was also lower (paired t‐test p = 0.046), and plasma NfL showed a similar trend (paired t‐test p = 0.16), as did plasma pTau217 (paired t‐test p = 0.084).”

    Human trialCSF180-day treatment phasen = 13

    Effect of choline supplementation in presymptomatic APOE ε4 carriers: a pilot study

    Alzheimer's & dementia (New York, N. Y.)

More on Choline

Multidisciplinary intensive outpatient rehabilitation program

downin humans1

1 study
  1. Multidisciplinary intensive outpatient rehabilitation program decreases NfL in humans (Parkinson's disease; compared with a home-based self-managed intervention).

    “NFL levels significantly decreased in the EXP group at both time points, whereas an increase was observed at follow-up in the CTRL group.”

    Human trialParkinson's disease; compared with a home-based self-managed interventionplasmapost-treatment and 3-month follow-upn = 40

    Effect of a multidisciplinary intensive outpatient rehabilitation program on plasma neurofilaments and myokines in Parkinson's disease: an exploratory analysis

    Journal of neuroengineering and rehabilitation

More on Multidisciplinary intensive outpatient rehabilitation program

Vaccinium corymbosum

no changein humans1

1 study
  1. Vaccinium corymbosum showed no clear effect on NfL in humans (cognitively healthy) (p for interaction 0.58).

    “or serum NFL [i.e., corresponding values were 26.2 (18.2-34.1) and 25.0 (17.1-33.0) pg/mL in the placebo group and 26.6 (18.2-35.0) and 28.0 (19.5-36.5) pg/mL in the blueberry group, p for interaction 0.58]”

    Human trialcognitively healthypowder20 g/d24 weeksn = 57

    Effects of a 24-week intervention with freeze-dried blueberries on brain health in older adults: A randomized double-blind, placebo-controlled trial

    Clinical nutrition ESPEN

More on Vaccinium corymbosum

Angiotensin

downin humans1

1 study
  1. Angiotensin decreases NfL in humans (coronary artery bypass grafting).

    “attenuation of postoperative NfL levels compared with placebo-treated participants”

    Human trialcoronary artery bypass graftingsubcutaneouslyplasma200 μg/kg/day21 daysn = 5

    Perioperative Angiotensin-(1-7) for Postoperative Cognitive Vulnerability Following Coronary Artery Bypass Surgery: A Pilot Case Series

    Research squarePreprint

More on Angiotensin

Dulaglutide

downin humans1

1 study
  1. Dulaglutide decreases NfL in participants with baseline NfL ≥56 pg/mL (-27.4% vs -14.2%).

    “Participants with NfL ≥56 pg/mL had a dulaglutide-associated 2-year reduction in NfL (-27.4% vs -14.2%; p = 0.003).”

    Human trialin participants with baseline NfL ≥56 pg/mL2 years

    Dulaglutide and neurodegeneration biomarkers: REWIND post hoc analysis

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Dulaglutide

Wim hof method

no changein humans1

1 study
  1. Wim hof method showed no clear effect on NfL in humans (multiple sclerosis).

    “No significant changes were observed for IL-1β, IL-6, IL-12p70, NfL, or GFAP.”

    Human trialmultiple sclerosis12 weeksn = 43

    Targeting low-grade inflammation in multiple sclerosis through the Wim Hof method or lifestyle intervention: a pilot comparative study

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

More on Wim hof method

All 56

Effects

53

Cognitive function

downin humans14mediatesin humans4no changein humans4

22 studies
  1. NfL is linked with cognitive function in humans (Indirect effect −0.0046 (95% CI −0.0089 to −0.0014); p=0.004; 18.05% mediated).

    “Mediation analyses identified significant indirect pathways through NfL linking depressive symptoms with poorer subsequent cognitive performance”

    HumansStatistical mediation of the prospective association between baseline depressive symptoms and subsequent cognitionmean interval 6.34 yearsn = 921

    Blood marker may link depressive symptoms to cognitive decline

    Brain, behavior, & immunity - health

  2. NfL was not clearly linked with cognitive function in humans within traditional diagnostic categories.

    “No significant associations between NfL levels and cognition were found within traditional diagnostic categories.”

    Humanswithin traditional diagnostic categoriesblood

    Cluster-based Cognitive Profiles and Their Relationship with Neurofilament Light Chain in Patients with Severe Mental Disorders of the Elderly

    Taiwanese Journal of Psychiatry

  3. NfL was not clearly linked with cognitive function in humans (obstructive sleep apnea syndrome).

    “Neither AHI, ESS scores nor serum NfL concentrations were significantly associated with verbal memory or problem-solving performance.”

    Humansobstructive sleep apnea syndrome

    CPAP Treatment Exposure, but Not Daytime Sleepiness or Neurofilament Light Chain, Is Associated with Cognitive Performance in Obstructive Sleep Apnea

    Journal of clinical medicine

  4. NfL is linked with worse cognitive function in non-Hispanic White participants.

    “Among NHW participants, higher p-tau181 and NfL were associated with poorer memory, executive function, processing speed, and language.”

    Humansin non-Hispanic White participants

    Independent associations of phosphorylated tau181 and neurofilament light with cognitive outcomes in the Health and Aging Brain Study-Health Disparities (HABS-HD)

    Journal of Alzheimer's disease : JAD

  5. NfL is linked with worse cognitive function in humans.

    “Higher NfL was associated with worse cognitive function in the total sample and in each race/ethnic group”

    Humansn = 4,214

    The association of blood-based biomarkers of neuropathology with cognitive performance and incident dementia in a diverse, nationally-representative sample of US adults

    medRxiv : the preprint server for health sciencesPreprint

  6. NfL is linked with worse cognitive function in humans (Uganda Aging Cohort Study).

    “Elevated plasma NfL was associated with worse overall cognition, learning/memory, attention, executive function, and motor performance”

    HumansUganda Aging Cohort Studyplasman = 560

    Plasma Biomarker Association with Cognition in Uganda

    AAIC 2025 abstract

  7. NfL is linked with worse cognitive function in humans (adjusted for demographics) (P < 0.05).

    “Higher plasma levels of NfL, GFAP, and pT217 were associated with lower cognitive performance on both MoCA and PACC (all P < 0.05).”

    Humansadjusted for demographicsplasman = 491

    Sleep Quality as a Modifier of Plasma pTau217 and GFAP Associations with Cognitive Function

    GSA 2025 abstract

  8. NfL is linked with worse cognitive function in humans.

    “Higher levels of each biomarker were associated with faster cognitive decline.”

    Humansblood25 yearsn = 1,864

    Blood biomarkers of neuronal injury and glial cell dysfunction and 25‐year cognitive decline and incident dementia in the ARIC study

    AAIC 2025 abstract

  9. NfL is linked with worse cognitive function in humans (0.006 SD unit/year worse cognitive decline per SD log NfL (95% CI 0.000-0.013)).

    “each SD increase in log NfL was associated with 0.006 (95% CI 0.000‐0.013) SD unit/year worse cognitive decline”

    Humansn = 2,699

    Associations between neurodegenerative plasma biomarkers and cognitive functioning and decline in India

    AAIC 2025 abstract

  10. NfL is linked with worse cognitive function in humans (linear β coefficients: -0.022 to -0.300).

    “Higher plasma levels of p ‐tau181, GFAP and NfL were associated with a greater decline in global cognitive function, verbal fluency, episodic memory and psychomotor speed (linear β coefficients: ‐0.022 to ‐0.300).”

    Humansplasmaup to 11 years

    Plasma biomarkers of Alzheimer's disease and related dementias and changes in cognitive function in US and Australian older individuals

    AAIC 2025 abstract

All 22

Alzheimer's disease

mediatesin humans2

2 studies
  1. NfL is linked with Alzheimer's disease in humans (Indirect effect 0.0033 (95% CI 0.0000 to 0.0073); p=0.046; 16.15% mediated).

    “NfL also mediated the prospective association between depressive symptoms and incident AD”

    HumansStatistical mediation of the prospective association between depressive symptoms and incident Alzheimer's disease; significance attenuated in fully adjusted modelsn = 445

    Blood marker may link depressive symptoms to cognitive decline

    Brain, behavior, & immunity - health

  2. NfL is linked with Alzheimer's disease in humans (association of CMM with AD).

    “The mediation analysis suggested that plasma NfL significantly mediated the association of CMM with AD.”

    Humansassociation of CMM with AD

    Cardiometabolic multimorbidity, peripheral biomarkers, and dementia in rural older adults: The MIND-China study

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Alzheimer's disease

Dementia

mediatesin humans2

2 studies
  1. NfL is linked with dementia in humans (edentulism association) (9.8%).

    “NfL mediated 9.8% of the dementia association but not cognitive impairment.”

    Humansedentulism association10-yearn = 4,238

    Blood markers account for a small part of tooth loss–dementia link

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. NfL is linked with dementia in humans (association between ILF and incident dementia) (7.3% mediated proportion).

    “In mediation models, higher NfL and p Tau181 accounted for modest proportions of the observed association between ILF and incident dementia, with estimated mediated proportions of 7.3% for NfL and 4.9% for p Tau181.”

    Humansassociation between ILF and incident dementiaplasman = 4,072

    Impaired lung function is associated with elevated blood biomarkers of AD/ADRD: unraveling the interplay with risk of dementia

    Scientific reports

More on Dementia

White matter hyperintensity volume

upin humans2

2 studies
  1. NfL is linked with higher white matter hyperintensity volume in humans (B = 0.02, p = 0.01).

    “Higher plasma NfL level was significantly associated with greater meta‐ROI ( B = ‐0.01, p = < 0.001), and WMH volumes ( B = 0.02, p = 0.01).”

    Humansadjusted for demographic and vascular covariates, intracranial volume and scanner differences

    Plasma neurofilament light chain, cognition, and MRI measures in community‐dwelling Hispanics

    AAIC 2025 abstract

  2. NfL is linked with higher white matter hyperintensity volume in humans (p < 0.001).

    “Higher plasma NfL levels at baseline were associated with steeper increases in ADAS-Cog scores and WMH volumes”

    Humansmean follow-up period of 62.5 months48.8% femalesn = 720

    Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration

    Alzheimer's research & therapy

More on White matter hyperintensity volume

Physical function

downin humans2

2 studies
  1. NfL is linked with worse physical function in humans (cognitively unimpaired).

    “Higher neurofilament light was associated with worse expanded short physical performance battery, slower 4 m gait speed, and slower 400 m gait speed in adjusted models.”

    Humanscognitively unimpairedn = 192

    Relationship of Alzheimer's Disease and Related Dementias Plasma Biomarkers With Mobility in Cognitively Unimpaired Older Adults

    The journals of gerontology. Series A, Biological sciences and medical sciences

  2. NfL is linked with worse physical function in humans (0.15 units (95% CI 0.21, 0.08) faster annual decline).

    “In participants with 2-fold higher concentrations of serum NfL, the annual rate of decline in physical functioning increased by 0.15 units (95% CI 0.21, 0.08).”

    Humansserum2-fold higher concentrations16 years

    Association of Neurofilament Light With the Development and Severity of Parkinson Disease

    Neurology

Dementia prediction discrimination

no changein humans1

1 study
  1. NfL was not clearly linked with dementia prediction discrimination in humans (beyond pTau217 or dementia risk scores).

    “Adding NfL did not significantly improve discrimination or model fit.”

    Humansbeyond pTau217 or dementia risk scores11 yearsn = 3,935

    Comparative analysis of plasma pTau217, NfL and eight modifiable risk scores for 11-year dementia prediction in the HUNT Study

    medRxivPreprint

Physical performance change

no changein humans1

1 study
  1. NfL was not clearly linked with physical performance change in humans (Baseline plasma biomarker; adjusted analysis).

    “we found no statistically significant associations between baseline NT1, NfL, or oAβ and two-year changes in physical performance.”

    HumansBaseline plasma biomarker; adjusted analysis2 years49.3% womensn = 506

    Plasma biomarkers of neurodegeneration and physical performance in older adults

    GeroScience

Cardiovascular death

no changein humans1

1 study
  1. NfL was not clearly linked with cardiovascular death in humans After adjustment including NT-proBNP.

    “showed no independent association with cardiovascular death after adjustment including NT-proBNP.”

    HumansAfter adjustment including NT-proBNPplasmaMedian follow-up of 10 yearsn = 806

    Nerve injury marker linked to death in community-living 75-year-olds

    European heart journal open

Ischemic stroke and myocardial infarction

no changein humans1

1 study
  1. NfL was not clearly linked with ischemic stroke and myocardial infarction in humans (Adjusted analysis).

    “Neurofilament light chain was not independently associated with ischaemic stroke or myocardial infarction”

    HumansAdjusted analysisplasmaMedian follow-up of 10 yearsn = 806

    Nerve injury marker linked to death in community-living 75-year-olds

    European heart journal open

More on Ischemic stroke and myocardial infarction

Gait speed

downin humans1

1 study
  1. NfL is linked with lower gait speed in humans (highest vs lowest quartile) (β: -0.013, 95% CI: -0.019; -0.006).

    “NfL (Model I; 4th quartile β: -0.013, 95% CI: -0.019; -0.006)”

    Humanshighest vs lowest quartile15 yearsn = 1,665

    Alzheimer’s blood markers linked to faster walking-speed decline

    Journal of cachexia, sarcopenia and muscle

All 53

Upstream

51

Age

upin humans5+2.6% per year

5 studies
  1. Age is linked with higher NfL in humans (+2.6% per year).

    “Between ages 40 and 80 years, expected NfL and GFAP concentrations increased by an average of 2.6% and 2.2% per year, respectively.”

    Humans

    Population-based reference equations and Z-scores for blood biomarkers of neurodegenerative diseases

    medRxivPreprint

  2. Age is linked with higher NfL in humans (Spearman's ρ=0.721, c<0.001).

    “NfL concentrations increased markedly with age (Spearman's ρ=0.721, c<0.001), with median values rising from 8.45pg/mL in individuals aged 18-34years to 23.4pg/mL in those aged ≥69years.”

    Humansbloodn = 211

    Age-specific benchmarks set for blood marker of nerve injury

    Revue neurologique

  3. Age is linked with higher NfL in humans.

    “Results showed a significant acceleration in sNfL levels after age 40, resulting in a nonlinear growth function.”

    Humansfemales

    Racial discrimination accelerates age-related increases in serum neurofilament light chain among African American women: examination of change from midlife to older adulthood

    The journals of gerontology. Series B, Psychological sciences and social sciences

  4. Age is linked with higher NfL in humans (unimpaired older adults) (p < 0.001).

    “Higher serum NfL levels were significantly positively associated with age (p < 0.001 for all domains).”

    Humansunimpaired older adultsserum8 yearsn = 174

    Does serum neurofilament light help predict accelerated cognitive ageing in unimpaired older adults?

    Frontiers in neuroscience

  5. Age is linked with higher NfL in humans (β=0.513, p<0.001).

    “Age (β=0.513, p<0.001) was by far the most important factor influencing sNfL”

    Humansserumn = 327

    Factors influencing serum neurofilament light chain levels in normal aging

    Aging

APOE

downin humans1no changein humans1upin humans1

3 studies
  1. APOE is linked with lower NfL in PSEN1 E280A carriers (f2=0.133).

    “and NfL (f2=0.133) among PSEN1 E280A carriers”

    Humansin PSEN1 E280A carriers

    Plasma Biomarker Profiles in a Colombian Cohort of Heterozygous APOE3-Christchurch Carriers

    Research SquarePreprint

  2. APOE was not clearly linked with NfL in Hispanics/Latinos.

    “but not with NfL”

    Humansin Hispanics/Latinos

    APOE and plasma AD biomarkers: The role of genetic ancestry in Hispanics/Latinos

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  3. APOE is linked with higher NfL in humans (cognitively unimpaired APOE ε4 homozygotes vs. non-carriers) (21.4 pg/ml vs. 15.5 pg/ml, p = 0.013).

    “Serum NfL concentration was increased in APOE ε4 homozygotes compared with non-carriers (mean 21.4 pg/ml (SD 9.5) vs. 15.5 pg/ml (3.8), p = 0.013)”

    Humanscognitively unimpaired APOE ε4 homozygotes vs. non-carriersserum

    Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly

    Alzheimer's research & therapy

More on APOE

Obesity

downin humans1upin humans1upin mice1

3 studies
  1. Obesity is linked with lower NfL in humans (obesity compared with normal weight) (median 1.72 pg/mL lower with obesity compared with normal weight (BMI 30 vs 20)).

    “Median NfL and GFAP concentrations were 1.72 (1.72-1.72) pg/mL and 12.6 (12.6-12.6) pg/mL lower, respectively, in participants with obesity compared with those with normal weight”

    Humansobesity compared with normal weight

    Glial Fibrillary Acidic Protein and Neurofilament Light Reference Intervals in Healthy Individuals

    JAMA network open

  2. Obesity is linked with higher NfL in humans (obesity (BMI > 30)).

    “NfL levels were elevated in obese participants”

    Humansobesity (BMI > 30)

    Reduced Blood Choline in Obesity Is Associated with Metabolic and Alzheimer's Biomarkers

    Aging and disease

  3. Obesity increases NfL in Mc4r-deficient obese mice.

    “Serum neurofilament light chain (sNfL) levels were also elevated.”

    Animalsin Mc4r-deficient obese mice

    Cognitive decline and neuroinflammation in a mouse model of obesity: An accelerating role of ageing

    Brain, behavior, and immunity

More on Obesity

Frailty

upin humans1mediatesin humans1

2 studies
  1. Frailty is linked with higher NfL in humans (older adults without dementia).

    “frail individuals showed significantly higher NfL levels in adjusted models.”

    Humansolder adults without dementian = 98

    Evaluating Physical Frailty as a Marker of Cognitive Health in Older Adults without Dementia

    Journal of geriatric psychiatry and neurology

  2. Frailty is linked with NfL in older adults with normal cognition or MCI.

    “frailty status significantly mediated the PA-NfL relationship”

    Humansin older adults with normal cognition or MCIn = 95

    ASSOCIATION OF PHYSICAL ACTIVITY WITH NEUROFILAMENT LIGHT IN NONDEMENTIA OLDER ADULTS AND THE MEDIATION OF FRAILTY

    GSA 2024 abstract

Type 2 diabetes

no changein humans1upin humans1

2 studies
  1. Type 2 diabetes was not clearly linked with NfL in humans (type 2 diabetes) (ηp2 = 0.01, p = .530).

    “There were no significant group differences on NfL levels (η p 2 = 0.01, p = .530)”

    Humanstype 2 diabetesplasman = 134

    Cognitively Unimpaired Older Adults with Type 2 Diabetes have Higher Levels of Plasma p ‐tau217

    AAIC 2025 abstract

  2. Type 2 diabetes is linked with higher NfL in humans (d = 0.19, 95% CI, 0.07 to 0.30).

    “History of type 2 diabetes was associated with increased NfL concentration (d = 0.19; 95% CI, 0.07 to 0.30; P = .04)”

    Humansplasman = 4,340

    Alzheimer Disease Blood Biomarker Concentrations Across Race and Ethnicity Groups in Middle-Aged Adults

    JAMA network open

More on Type 2 diabetes

Depressive symptoms

upin humans1no changein humans1

2 studies
  1. Depressive symptoms are linked with higher NfL in humans (compared to low symptoms) (SMD = 0.10, 95 % CI: 0.02-0.18).

    “High depressive symptoms (19 %) were linked to higher NfL (standardized mean differences [SMD] = 0.10, 95 % confidence interval [CI: 0.02-0.18]”

    Humanscompared to low symptomsn = 2,929

    Depressive symptoms and plasma AT(N) biomarkers among cognitively healthy and mild cognitively impaired in a diverse cohort

    Neurobiology of aging

  2. Depressive symptoms were not clearly linked with NfL in humans.

    “there was no significant association between changes in depression and NfL levels in SCGs”

    Humansplasma16-monthn = 38

    Caregiving-Related Depression Increases Neuroinflammation in Spousal Caregivers to Individuals With Cognitive Impairment: A Longitudinal Study

    The journals of gerontology. Series A, Biological sciences and medical sciences

Delirium

upin humans1no changein humans1

2 studies
  1. Delirium is linked with higher NfL in humans (predicted value of 1.2 pg/mL (95% CI 1.02 to 1.40, p=0.029) increase).

    “Delirium was directly linked with a predicted value of 1·2 pg/mL (95% CI 1·02 to 1·40, p=0·029) increase in NfL.”

    Humansn = 210

    Delirium, neurofilament light chain, and progressive cognitive impairment: analysis of a prospective Norwegian population-based cohort

    The lancet. Healthy longevity

  2. Delirium was not clearly linked with NfL in humans (postoperative) (ρ = .491, p = .09).

    “but not NfL (p = .09, ρ = .491) or Ab42/40-ratio (p = .18, ρ = .394)”

    Humanspostoperativecerebrospinal fluidn = 13

    Cohort Analysis of the Association of Delirium Severity With Cerebrospinal Fluid Amyloid-Tau-Neurodegeneration Pathologies

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Delirium

Allostatic load

mediatesin humans1upin humans1

1 study
  1. Allostatic load is linked with NfL in humans among women (indirect effect = +0.00042 ± 0.00019, P = 0.025; mediation proportion = 30%).

    “BMI's association with δNfL was significantly mediated through ALtotal among women”

    Humansamong womenplasma7.72 ± 1.28 yfemales

    BMI and Allostatic Load Are Directly Associated with Longitudinal Increase in Plasma Neurofilament Light among Urban Middle-Aged Adults

    The Journal of nutrition

  2. Allostatic load is linked with higher NfL in humans.

    “a pattern replicated for ALtotal.”

    Humansplasma7.72 ± 1.28 yn = 608

    BMI and Allostatic Load Are Directly Associated with Longitudinal Increase in Plasma Neurofilament Light among Urban Middle-Aged Adults

    The Journal of nutrition

More on Allostatic load

Amyotrophic lateral sclerosis

upin humans1

1 study
  1. Amyotrophic lateral sclerosis is linked with higher NfL in humans (presymptomatic ALS) (r = -0.37, P < 0.001).

    “Neurofilament light rose sharply in the 2-3 years preceding diagnosis (r = -0.37, P < 0.001).”

    Humanspresymptomatic ALSserumn = 270

    Proteomic and Functional Signatures of Phenoconversion in Presymptomatic Amyotrophic Lateral Sclerosis

    Journal of clinical neuromuscular disease

More on Amyotrophic lateral sclerosis

Adiposity

downin humans1

1 study
  1. Adiposity is linked with lower NfL in humans.

    “In males, increasing adiposity correlated with lower p-tau217 and neurofilament light chain (NfL).”

    Humansmales

    Mapping sex-specific associations of adiposity with age-related cognitive decline and multimodal Alzheimer's pathology

    Alzheimer's & dementia : the journal of the Alzheimer's Association

All 51

Associations

329

Cognitive function

downin humans25

25 studies
  1. NfL is associated with cognitive function in humans (baseline) (β = -0.33, SE = 0.13, adjusted p = .042).

    “At baseline, higher NfL was associated with poorer cognition (β = -0.33, SE = 0.13, adjusted p = .042).”

    Human trialbaselinen = 99

    The impact of exercise on blood-based biomarkers of Alzheimer's disease in cognitively unimpaired older adults

    GeroScience

  2. NfL is associated with cognitive function in humans (cognitively unimpaired) (r = −0.116 to −0.185; P < 0.01).

    “NfL correlated with all domains ( r = −0.116 to −0.185; P < 0.01)”

    Humanscognitively unimpairedn = 552

    Decomposed arterial stiffness and NfL–cognition association in older adults: The IGNITE study

    Alzheimer's & dementia (Amsterdam, Netherlands)

  3. NfL predicts cognitive function in humans (Down syndrome, controlling for age) (posterior distributions ≥ 94.75%).

    “Protein baseline levels were associated with cognitive decline over time while controlling for age in the whole cohort (all posterior distributions ≥ 94.75%).”

    HumansDown syndrome, controlling for ageplasman = 59

    Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome

    Neurology

  4. NfL predicts cognitive function in humans (non-ε4 carriers) (β = -0.025 [95% CI, -0.031 to -0.020]).

    “higher levels of NfL and GFAP were associated with faster cognitive decline only in non-ε4 carriers (β = -0.025 [95% CI, -0.031 to -0.020]) and -0.017 [95% CI, -0.022 to -0.012], respectively)”

    Humansnon-ε4 carriersn = 2,008

    Blood Biomarkers of Alzheimer Disease and Rates of Global and Domain-Specific Cognitive Decline

    JAMA network open

  5. NfL is associated with cognitive function in humans (Cluster A subgroup of severe mental disorders) (r = -0.486, p < 0.01).

    “In this subgroup, NfL levels were significantly and negatively correlated with orientation ( r = −0.452, p < 0.05), attention/calculation ( r = −0.435, p < 0.05), memory ( r = −0.352, p < 0.05), and comprehension ( r = −0.486, p < 0.01).”

    HumansCluster A subgroup of severe mental disordersblood

    Cluster-based Cognitive Profiles and Their Relationship with Neurofilament Light Chain in Patients with Severe Mental Disorders of the Elderly

    Taiwanese Journal of Psychiatry

  6. NfL is associated with cognitive function in humans.

    “Cross-sectionally, NfL and GFAP showed the broadest associations.”

    Humansn = 1,170

    Comparative analyses of Alzheimer's disease blood biomarkers and cognitive domains

    medRxiv : the preprint server for health sciencesPreprint

  7. NfL is associated with cognitive function in humans (outpatients) (β = -0.09, p = 0.010).

    “showed associations with worse cognitive outcomes both directly and indirectly (β = -0.09, p = 0.010)”

    Humansoutpatientsplasman = 206

    Blood neurodegeneration biomarkers and the muscle-brain axis in older adults: physical performance as a functional mediator of cognition

    Experimental gerontology

  8. NfL is associated with cognitive function in humans (low-education groups) (β=-1.02, p=0.006).

    “amplified neurodegeneration effects (β=-1.02, p=0.006)”

    Humanslow-education groups

    Equity and Transportability of Plasma ATN Phenotypes in a Population-Representative U.S. Aging Cohort

    medRxiv : the preprint server for health sciencesPreprint

  9. NfL is associated with cognitive function in humans (adjusted for age, sex, education, habitat, and comorbidities) (β = -1.94 × 10−3, p = 0.002).

    “higher NfL (β = -1.94 × 10−3, p = 0.002) were associated with greater cognitive decline over time.”

    Humansadjusted for age, sex, education, habitat, and comorbiditiesn = 1,181

    Longitudinal Associations Between Neurodegenerative Biomarkers and Cognitive Decline in Older Adults: Insights From the LASI-DAD Study

    Journal of the American Geriatrics Society

  10. NfL predicts cognitive function in humans.

    “NfL also predicted faster memory decline.”

    Humans

    Change in Plasma Biomarkers of Alzheimer’s Disease From Midlife to Late-Life and Associations With Cognitive Change

    GSA 2025 abstract

All 27

Age

upin humans14upin dogs1upin marmosets1upin mice1+1+2.9% per year

17 studies
  1. Age predicts NfL in CSF-confirmed participants.

    “age emerged as the most consistent predictor of plasma biomarker levels, particularly NFL and pTau181”

    Humansin CSF-confirmed participantsn = 116

    Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease

    Aging brain

  2. Age is associated with NfL in humans (2.90% per year).

    “In serum, NfL rose 2.90% and GFAP 2.69% per year (both p < .0001).”

    Humansblood

    Establishing demographic-based normative values for neurofilament light chain and glial fibrillary acidic protein in serum and plasma samples

    Multiple sclerosis journal - experimental, translational and clinical

  3. Age is associated with NfL in humans (r = 0.83).

    “NfL concentrations demonstrated a significant positive polynomial correlation with age (r = 0.83, P < 0.001)”

    Humans

    Age-Dependent z Scores and eGFR-Adjusted Reference Ranges for Neurofilament Light: A Practical Approach for Clinical Laboratories

    Clinical chemistry

  4. Age is associated with NfL in adults with co-occurring epilepsy and intellectual disability (r = .31, p = .01).

    “Age-corrected Z-scores of NfL were still significantly associated with age (r = .31, p = .01).”

    Humansin adults with co-occurring epilepsy and intellectual disability

    Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury

    Epilepsia

  5. Age is associated with NfL in humans (Parkinson's disease).

    “Age strongly correlated with neurofilament CSF levels, both light and heavy chain, with YKL-40 and with tau species.”

    HumansParkinson's diseasecerebrospinal fluidn = 95

    Effect of aging on biomarkers and clinical profile in Parkinson's disease

    Journal of neurology

  6. Age is associated with NfL in humans (r = 0.81 (95% CI 0.78-0.83), p < 0.0001).

    “The spearman r of the association with age was 0.81 (95% CI 0.78-0.83), p < 0.0001 and 0.82 (95% CI 0.79-0.85), p < 0.0001 for serum and CSF NfL, respectively.”

    Humans

    Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases

    Journal of neurology

  7. Age is associated with NfL in humans.

    “We found five plasma peptides (NfL92, NfL101, NfL117, NfL324 and NfL530) significantly associated with age”

    Humansplasman = 102

    Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer's disease

    Brain communications

  8. Age is associated with NfL in humans (healthy controls).

    “Age and body mass index affected sNfL values, and age was found to be the most important factor.”

    Humanshealthy controls

    Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults

    International journal of molecular sciences

  9. Age is associated with NfL in individuals with mild cognitive impairment due to Alzheimer's disease.

    “while NfL was correlated with higher age in AD-MCI, no significant correlation was found for t-tau”

    Humansin individuals with mild cognitive impairment due to Alzheimer's diseasen = 144

    Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease

    Neurobiology of aging

  10. NfL is associated with age in people with HIV and people without HIV.

    “Higher NfL related to increasing age in both groups.”

    Humansin people with HIV and people without HIVplasma

    Relationships between plasma neurofilament light chain protein, cognition, and brain aging in people with HIV

    AIDS (London, England)

All 18

Mortality

upin humans16upin mice1HR 1.21–4.92

17 studies
  1. NfL is associated with mortality in humans (Patients hospitalized for heart failure; adjusted analysis) (Adjusted HR 1.78 (95% CI 1.50–2.11)).

    “higher levels of both p-tau217 and NfL were independently associated with all cause-mortality but not with HF rehospitalization.”

    HumansPatients hospitalized for heart failure; adjusted analysisMedian follow-up 3.6 years31% femalesn = 491

    Brain markers are linked to higher risk of death in heart failure

    ESC Congress 2026 abstract

  2. NfL is associated with mortality in humans (Association independent of cognition and activities of daily living) (HR 1.21-1.38 across cohorts).

    “NfL was the only biomarker consistently associated with mortality (HR 1.21-1.38)”

    HumansAssociation independent of cognition and activities of daily livingUp to 16 yearsn = 559

    Nerve-cell injury marker linked to death risk at ages 92–107

    medRxivPreprint

  3. NfL is linked with a higher risk of mortality in humans.

    “Higher NfL concentrations were associated with increased risks of transitions from healthy to PD, dementia, and death”

    Humansplasman = 19,645

    The interplay of air pollution with plasma neurodegenerative markers and metabolome for dementia, Parkinson's disease and all-cause mortality risks and transitions: The UK Biobank study

    Ecotoxicology and environmental safety

  4. NfL is associated with mortality in humans (Cognitively healthy Dutch centenarians) (HR 1.29, 95% CI 1.09–1.53).

    “plasma neurofilament light chain (NfL) levels (HR = 1.29, 95% CI: 1.09-1.53)”

    HumansCognitively healthy Dutch centenariansplasman = 247

    Peripheral Epigenetic Aging Predicts Survival in Cognitively Healthy Centenarians Independent of Brain Aging-Related Biomarkers

    medRxivPreprint

  5. NfL is associated with mortality in humans (Japanese centenarians) (HR 1.36; 95% CI, 1.17 to 1.57).

    “Higher NfL levels were also associated with increased mortality (hazard ratio, 1.36; 95% CI, 1.17 to 1.57)”

    HumansJapanese centenariansplasma17 yearsn = 495

    Biomarkers, Cognitive Function, and Mortality in Centenarians

    JAMA network open

  6. NfL is associated with mortality in adults with co-occurring epilepsy and intellectual disability (Log rank p = .04, HR p = .007).

    “carbamazepine use (χ2 = 4.38, p = .04), and mortality (Log rank p = .04; hazard ratio [HR] p = .007).”

    Humansin adults with co-occurring epilepsy and intellectual disability

    Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury

    Epilepsia

  7. NfL is linked with a higher risk of mortality in humans (fully adjusted models) (HR 1.90 (95% CI 1.55-2.32)).

    “1.90 (95% CI 1.55-2.32) for NfL, and 1.23 (95% CI 1.09-1.37) for UCH-L1.”

    Humansfully adjusted modelsplasma11.1 yearsn = 917

    Circulating Biomarkers of Neurodegeneration and All-Cause and Dementia-Specific Mortality

    Neurology

  8. NfL predicts mortality in humans.

    “All four markers significantly predicted 6-year mortality.”

    Humans6-yearn = 4,214

    The association of blood-based biomarkers of neuropathology with cognitive performance and incident dementia in a diverse, nationally-representative sample of US adults

    medRxiv : the preprint server for health sciencesPreprint

  9. NfL predicts mortality in persons with chronic coronary syndrome (HR 1.36 (95% CI 1.10-1.68)).

    “Participants with higher NfL levels had increased rates of all-cause and cardiovascular mortality (Hazard ratio per increase by one standard deviation (95 % confidence interval): all-cause mortality: 1.36 (1.10-1.68)”

    Humansin persons with chronic coronary syndromen = 379

    Associations of blood-based biomarkers of neurodegenerative diseases with mortality, cardio- and cerebrovascular events in persons with chronic coronary syndrome

    Experimental gerontology

  10. NfL is linked with a higher risk of mortality in humans (fivefold higher concentrations) (HR 2.13, 95% CI 1.76–2.58).

    “NfL (HR = 2.13, 95% CI: 1.76, 2.58), and GFAP (HR = 1.43, 95% CI: 1.08, 1.90) were separately associated with increased risk of overall mortality”

    Humansfivefold higher concentrationsn = 1,327

    Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study

    Journal of the American Geriatrics Society

All 17

Dementia

upin humans12RR 1.72

12 studies
  1. NfL is associated with dementia in humans (exploratory analyses).

    “plasma neurofilament light chain were associated with incident dementia”

    Humansexploratory analysesmedian of 4.7 yearsn = 730

    Incidence of dementia and mild cognitive impairment in two Indigenous Bolivian cohorts

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. NfL is linked with a higher risk of dementia in humans.

    “Higher NfL concentrations were associated with increased risks of transitions from healthy to PD, dementia, and death”

    Humansplasman = 19,645

    The interplay of air pollution with plasma neurodegenerative markers and metabolome for dementia, Parkinson's disease and all-cause mortality risks and transitions: The UK Biobank study

    Ecotoxicology and environmental safety

  3. NfL is linked with a higher risk of dementia in humans (high vs low range) (RR 1.72, 95% CI 1.31-2.27).

    “high NfL: RR 1.72, 95% CI 1.31-2.27”

    Humanshigh vs low range4 yearsn = 4,971

    Plasma p-tau217 and NfL predict incident dementia in the community

    medRxivPreprint

  4. NfL is associated with dementia in adults with co-occurring epilepsy and intellectual disability (χ2 = 10.73, p = .001).

    “Elevated NfL was associated with significant adaptive decline (χ2 = 7.20, p = .007), suspected dementia (χ2 = 10.73, p = .001)”

    Humansin adults with co-occurring epilepsy and intellectual disability

    Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury

    Epilepsia

  5. NfL predicts dementia in humans (OR=1.33).

    “NfL was predictive of 6-year incident dementia in our sample (OR=1.33).”

    Humans6-yearn = 4,214

    The association of blood-based biomarkers of neuropathology with cognitive performance and incident dementia in a diverse, nationally-representative sample of US adults

    medRxiv : the preprint server for health sciencesPreprint

  6. NfL is linked with a higher risk of dementia in humans (HR: 1.83, 95% CI: 1.11–3.01).

    “Cox models showed that high CSF NfL levels were associated with an increased risk of first progression (HR: 1.83, 95% CI: 1.11–3.01; p = 0.018)”

    Humanscerebrospinal fluid

    Evaluating CSF NfL and Hippocampal Atrophy as Predictors of Dementia Progression: A 20‐Year Longitudinal Study

    AAIC 2025 abstract

  7. NfL predicts dementia in humans among individuals with impaired kidney function (HR, 3.85 [95% CI 1.87-7.95]).

    “The relationship between increased (high vs low) NfL and dementia was stronger among individuals with impaired (vs preserved) kidney function (HR, 3.85 [95% CI 1.87-7.95] vs HR, 1.84 [95% CI 1.34-2.53], respectively).”

    Humansamong individuals with impaired kidney functionmean 8.3 yearsn = 2,279

    Kidney Function, Alzheimer Disease Blood Biomarkers, and Dementia Risk in Community-Dwelling Older Adults

    Neurology

  8. NfL is linked with a higher risk of dementia in humans (adjusted HR 1.77, 95% CI, 1.07-2.92).

    “Elevated NfL (adjusted HR 1.77, 95% CI, 1.07-2.92) and TSDD exposure (HR 1.55, 1.08-2.24) were independently associated with incident dementia risk.”

    Humans

    Joint Effects of Anticholinergic Burden and Neurofilament Light on Dementia Risk: The Shanghai Aging Study

    CNS neuroscience & therapeutics

  9. NfL is linked with a higher risk of dementia in humans following an MCI diagnosis (HR = 1.467 (95% CI: 1.152-1.69)).

    “neurofilament light (HR = 1.467 (95% CI: 1.152-1.69)) associated with increased dementia risk.”

    Humansfollowing an MCI diagnosisserumn = 413

    Predictors of Bi-directional Transitions From Mild Cognitive Impairment in a Diverse Cohort

    The journals of gerontology. Series A, Biological sciences and medical sciences

  10. NfL is linked with a higher risk of dementia in humans (RRR=1.95, 95% CI: 1.29, 2.94).

    “NFL (RRR= 1.95, 95% CI: 1.29, 2.94)]”

    Humansplasmamedian follow-up of 6.5 years61% femalesn = 919

    BLOOD-BASED BIOMARKERS FOR ALZHEIMER’S DISEASE AND NEURODEGENERATION IN RELATION TO INCIDENT COGNITIVE STATUS

    GSA 2024 abstract

All 12

More on Dementia

Alzheimer's disease

upin humans11HR 1.19–1.31

11 studies
  1. Alzheimer's disease is associated with NfL in humans (compared with healthy term newborns and aged controls).

    “NfL was highest in Alzheimer’s disease and lowest in newborns.”

    Humanscompared with healthy term newborns and aged controlsplasma

    Newborns had higher blood tau markers than Alzheimer’s patients

    Brain communications

  2. Alzheimer's disease is associated with NfL in humans (stepwise increase from cognitively unimpaired to dementia).

    “with stepwise increases of p-tau217, NfL and GFAP from cognitively unimpaired to dementia (p < 0.05).”

    Humansstepwise increase from cognitively unimpaired to dementiaplasman = 967

    Blood-based biomarkers of Alzheimer's disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms

    NPJ dementia

  3. NfL is associated with Alzheimer's disease in humans (Baseline concentration standardized as a covariate-adjusted z-score) (HR 1.31; 95% CI 1.22–1.41).

    “AD (HR 1.31; 95% CI, 1.22-1.41, p < 0.001)”

    HumansBaseline concentration standardized as a covariate-adjusted z-scoreplasma

    Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank

    Journal of neurology

  4. Alzheimer's disease is associated with NfL in humans (preclinical Alzheimer's disease).

    “We observed elevated neurofilament light chain in preclinical Alzheimer's disease plasma for two measures (NfL101 and NfL324)”

    Humanspreclinical Alzheimer's diseaseplasman = 102

    Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer's disease

    Brain communications

  5. Alzheimer's disease is associated with NfL in humans (Faster increase: β 2.47, 95% CI 1.04–3.89).

    “NfL (β = 2.47 [95% CI: 1.04-3.89]) and GFAP (β = 4.45 [95% CI: 1.38-7.51]) exhibited a faster increase in individuals progressing to DAT.”

    HumansApproximately 8 yearsn = 305

    Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study

    The Lancet regional health. Europe

  6. NfL is associated with Alzheimer's disease in humans (Without dementia at baseline) (HR 1.19, 95% CI 1.03–1.36).

    “Higher levels of P-tau181 (HR = 1.32 [95% CI: 1.17-1.51]), NfL (HR = 1.19 [95% CI: 1.03-1.36]), and GFAP”

    HumansWithout dementia at baselinen = 1,007

    Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study

    The Lancet regional health. Europe

  7. NfL predicts Alzheimer's disease in humans.

    “NfL, Aβ42 and Aβ42/40 significantly outperformed all plasma proteins in differentiating AD dementia from NC”

    Humansplasma

    Diagnostic and predictive power of plasma proteins in Alzheimer's disease: a cross-sectional and longitudinal study in China

    Scientific reports

  8. Alzheimer's disease is associated with NfL in humans (clinical Alzheimer's disease).

    “AD cases had elevated NFL levels, while no significant group differences were seen in the preclinical phase”

    Humansclinical Alzheimer's diseaseplasman = 142

    Elevated plasma neurofilament light in aging reflects brain white-matter alterations but does not predict cognitive decline or Alzheimer's disease

    Alzheimer's & dementia (Amsterdam, Netherlands)

  9. NfL raises the risk of Alzheimer's disease in humans (effect size 1.60).

    “plasma neurofilament light chain (1.60, I2 = 37%), and C-reactive protein (1.30, I2 = 25%) are genetic biomarkers that show significant predictive values.”

    Review

    Early Laboratory Biomarkers as Risk Factors for Alzheimer's Disease: A Systematic Review and Meta-analysis

    AL-Kindy College Medical Journal

  10. NfL is associated with Alzheimer's disease in humans (AD compared with controls) (1.7-1.8-fold higher concentrations in AD than controls).

    “Across cohorts, blood and CSF NfL concentrations are higher in AD than controls, with reported 1.7-1.8-fold elevations”

    ReviewAD compared with controlsblood and cerebrospinal fluid

    Neurofilament light chain in Alzheimer's disease

    Clinica chimica acta; international journal of clinical chemistry

All 12

More on Alzheimer's disease

Cognitive impairment

upin humans7HR 1.34

7 studies
  1. NfL is associated with cognitive impairment in humans (HR 1.34, 95% CI 1.06–1.69).

    “both NfL (HR = 1.34, 95% CI 1.06-1.69, P = 0.014) and p-tau217 (HR = 1.47, 95% CI 1.14-1.89, P = 0.003) remained associated with incident cognitive impairment.”

    HumansCognitively unimpaired patients with obstructive sleep apnea; jointly modeled with p-tau217PlasmaMedian follow-up of 4.18 yearsn = 286

    Blood markers linked to later cognitive problems in sleep apnea

    Sleep & breathing = Schlaf & Atmung

  2. NfL is linked with a higher risk of cognitive impairment in diabetic individuals (OR 1.04, 95% CI 1.010-1.071, P = .031).

    “each unit increase in serum NfL was associated with increased odds of cognitive impairment (odds ratio 1.04, 95% confidence interval: 1.010-1.071, P = .031)”

    Humansin diabetic individualsserumn = 179

    Association between serum NfL and cognitive functioning in older adults with diagnosed diabetes: A cross-sectional study from NHANES

    Medicine

  3. NfL predicts cognitive impairment in humans (cognitively unimpaired at baseline).

    “Subjects with older age, lower Aβ42, higher NfL, and higher REG4 at baseline had increased cognitive impairment risk during follow-up.”

    Humanscognitively unimpaired at baselineduring follow-upn = 298

    CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly

    Science advances

  4. NfL is associated with cognitive impairment in humans within PWH.

    “Within PWH, NfL was higher with higher cardiovascular risk, cognitive impairment and a greater BAG.”

    Humanswithin PWHplasma

    Relationships between plasma neurofilament light chain protein, cognition, and brain aging in people with HIV

    AIDS (London, England)

  5. NfL predicts cognitive impairment in humans (AUC 0.908, 95% CI 0.851- 0.966).

    “Plasma NFL at a cut-point of 20.58pg/mL had the highest AUC (0.908, 95% CI 0.851- 0.966) for discriminating cognitive impairment”

    Humansplasma collected using acid citrate dextroseblood

    Blood Biomarkers Discriminate Cerebral Amyloid Status and Cognitive Diagnosis when Collected with ACD-A Anticoagulant

    Current Alzheimer research

  6. NfL predicts cognitive impairment in humans (AUC 0.908, 95% CI 0.851-0.966).

    “Plasma NFL at a cut-point of 20.58pg/mL had the highest AUC (0.908, 95% CI 0.851-0.966) for discriminating cognitive impairment”

    Humansplasma

    Discernment of cerebral amyloid and cognitive status using ultrasensitive blood biomarkers collected with a non-traditional anticoagulant

    Research SquarePreprint

  7. NfL is associated with cognitive impairment in humans (P < .001).

    “NfL levels were significantly associated with diagnostic groups (Normal Cognition [NC], mild cognitive impairment [MCI], Dementia; P < .001)”

    Humans

    Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Cognitive impairment

Sarcopenia

upin humans6HR 1.2

6 studies
  1. Sarcopenia is associated with NfL in humans (sarcopenic vs controls).

    “Plasma CAF22 and NfL were elevated, while BDNF was reduced.”

    Humanssarcopenic vs controlsmales

    Integrating EMG and plasma biomarkers to characterize neuromuscular remodeling in sarcopenia

    Neuromuscular disorders : NMD

  2. NfL is associated with sarcopenia in humans (RRR 1.37, 95% CI 1.16–1.61).

    “NfL was associated with sarcopenia (RRR: 1.37; 95% CI: 1.16–1.61; p < 0.001)”

    Humansn = 1,429

    Association between neurofilament light chain, glial fibrillary acidic protein, and sarcopenia in older Indian adults: evidence from LASI-DAD

    BMC geriatrics

  3. NfL is linked with a higher risk of sarcopenia in humans (HR 1.20 [1.10; 1.30], p < 0.001).

    “NfL was significantly linked to sarcopenia development (HR 1.20 [1.10; 1.30], p < 0.001)”

    Humans12 yearsn = 2,291

    Association of Alzheimer's Disease Blood Biomarkers With Sarcopenia Incidence and Progression: A 12-Year Population-Based Study

    Journal of cachexia, sarcopenia and muscle

  4. NfL predicts sarcopenia in patients with Alzheimer's disease (AUC = 0.701, p < 0.001).

    “Plasma NfL exhibited moderate accuracy in diagnosing sarcopenia (area under the curve; AUC = 0.701, p < 0.001)”

    Humansin patients with Alzheimer's diseaseplasma

    Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer's diseases

    Acta neurologica Belgica

  5. NfL predicts sarcopenia in humans (COPD) (AUC = 0.806, p < 0.05).

    “Plasma NfL also demonstrated an acceptable accuracy in diagnosing sarcopenia in controls (AUC = 0.757, p < 0.05) and COPD (AUC = 0.806, p < 0.05) patients.”

    HumansCOPDplasmamalesn = 139

    Plasma levels of Neurofilament light chain correlate with handgrip strength and sarcopenia in patients with chronic obstructive pulmonary disease

    Respiratory investigation

  6. NfL predicts sarcopenia in humans (AUC = 0.726, P < 0.001).

    “NfL concentration displayed acceptable diagnostic accuracy for sarcopenia (area under the curve = 0.726, P < 0.001).”

    Humansn = 300

    Plasma neurofilament light levels associate with muscle mass and strength in middle-aged and older adults: findings from GenoFit

    Journal of cachexia, sarcopenia and muscle

  7. NfL is associated with sarcopenia in humans (P < 0.001).

    “Neurofilament light chain levels were associated with grip strength and SMI (P = 0.005 and P = 0.045, respectively) and were significantly elevated in sarcopenic individuals, compared with non-sarcopenic participants (P < 0.001).”

    Humansn = 300

    Plasma neurofilament light levels associate with muscle mass and strength in middle-aged and older adults: findings from GenoFit

    Journal of cachexia, sarcopenia and muscle

More on Sarcopenia

Mild cognitive impairment

upin humans6

6 studies
  1. NfL predicts mild cognitive impairment in humans (amyloid-negative subjective cognitive decline) (AUC 0.686).

    “although NfL demonstrated modest discrimination for MCI conversion (area under the curve [AUC] 0.686, p=0.008).”

    Humansamyloid-negative subjective cognitive declinefour yearsn = 65

    Comparative Prognostic Performance of Hippocampal Volume and Plasma Biomarkers in Amyloid-Negative Subjective Cognitive Decline: A Four-Year Follow-up

    Journal of clinical neurology (Seoul, Korea)

  2. NfL is linked with a higher risk of mild cognitive impairment in aluminum workers.

    “GFAP, NfL, and P-tau396 were positively associated with MCI”

    Humansin aluminum workersplasman = 382

    Integrated Assessment of Internal Metal Mixtures and Plasma Neurodegeneration Biomarkers in Relation to Mild Cognitive Impairment among Aluminum Workers

    Environmental science & technology

  3. NfL predicts mild cognitive impairment in humans (older adults receiving psychiatric treatment for mood or anxiety disorders).

    “Logistic regression identified plasma NfL as a marker of MCI (P < .05) in this sample.”

    Humansolder adults receiving psychiatric treatment for mood or anxiety disorders

    Plasma Biomarkers and Clinical Indicators for Identifying Mild Cognitive Impairment in Older Adults With Psychiatric Disorders

    Journal of geriatric psychiatry and neurology

  4. Mild cognitive impairment is associated with NfL in humans (older adults receiving psychiatric treatment for mood or anxiety disorders).

    “MCI patients exhibited higher p-tau217 (P = .003) and NfL (P = .042) levels”

    Humansolder adults receiving psychiatric treatment for mood or anxiety disorders

    Plasma Biomarkers and Clinical Indicators for Identifying Mild Cognitive Impairment in Older Adults With Psychiatric Disorders

    Journal of geriatric psychiatry and neurology

  5. Mild cognitive impairment is associated with NfL in humans.

    “significantly associated with higher HbA1c and systolic blood pressure, and elevated neuronal markers such as β-Amyloid, T tau, and Nfl.”

    Humansn = 184

    Neuronal Biomarkers and Micronutrient Status in Adults with Mild Cognitive Impairment

    Nutrients

  6. NfL is associated with mild cognitive impairment in humans (chronic coronary syndrome).

    “NfL was associated with increased risk of MCI”

    Humanschronic coronary syndrome10 yearsn = 363

    Prospective associations of blood-based biomarkers of neurodegenerative diseases with cognitive performance in a cohort of patients with chronic coronary syndrome

    Journal of Alzheimer's disease : JAD

  7. NfL is linked with a higher risk of mild cognitive impairment in humans (RRR=1.44, 95% CI: 1.11, 1.87).

    “NFL (RRR= 1.44, 95% CI: 1.11, 1.87)].”

    Humansplasmamedian follow-up of 6.5 years61% femalesn = 919

    BLOOD-BASED BIOMARKERS FOR ALZHEIMER’S DISEASE AND NEURODEGENERATION IN RELATION TO INCIDENT COGNITIVE STATUS

    GSA 2024 abstract

More on Mild cognitive impairment

White matter hyperintensities

upin humans6

6 studies
  1. NfL is associated with white matter hyperintensities in humans (community-dwelling, dementia-free).

    “Participants with higher NfL showed steeper TBTV decline, ventricular enlargement, hippocampal and amygdala shrinkage, and faster WMH accumulation.”

    Humanscommunity-dwelling, dementia-freebrainup to 6 yearsn = 361

    Blood Biomarkers of Alzheimer's Disease and Patterns of Structural Brain Changes in the Community

    Annals of neurology

  2. White matter hyperintensities are associated with NfL in Mexican American adults.

    “In addition, the association between WMH volume and NfL was steeper in the MA group.”

    Humansin Mexican American adults

    Associations Between Cardiovascular Risk Factors and Neurofilament Light Levels Among US Mexican American Adults

    Brain and behavior

  3. NfL is associated with white matter hyperintensities in humans.

    “NfL was positively associated with white matter hyperintensities (WMH) and white matter (WM) free water.”

    Humanswhite mattern = 251

    Plasma and neuroimaging biomarkers of small vessel disease and Alzheimer's disease in a diverse cohort: MESA

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  4. NfL is associated with white matter hyperintensities in humans (non-demented) (β = 0.0798, SE = 0.0436, p = 0.0344).

    “A positive association was also observed between NfL levels and WMH level (β = 0.0798, SE = 0.0436, p = 0.0344), even after adjusting for covariates.”

    Humansnon-dementedn = 202

    Plasma Neurofilament Light Links to Brain Tissue Loss, Ventricular Enlargement, and Elevated White Matter Hyperintensities

    AAIC 2025 abstract

  5. NfL is associated with white matter hyperintensities in humans.

    “All measures (VRFs, gait, behavioral, plasma GFAP, plasma NfL) were associated with white matter hyperintensities (WMHs) but mainly in intermediate and high age strata.”

    Humans

    Vascular risk, gait, behavioral, and plasma indicators of VCID

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  6. NfL is associated with white matter hyperintensities in humans (without a history of TIA or stroke) (β = 2,242.9, p = 0.0036).

    “Associations were also present with WMH volume (β = 2,242.9, p = 0.0036).”

    Humanswithout a history of TIA or strokeserumn = 633

    Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults: The Cardiovascular Health Study

    Neurology

More on White matter hyperintensities

Estimated glomerular filtration rate

downin humans3upin humans2

5 studies
  1. Estimated glomerular filtration rate is associated with NfL in humans (r = -0.78).

    “a negative exponential correlation with eGFR (r = -0.78, P < 0.001).”

    Humans

    Age-Dependent z Scores and eGFR-Adjusted Reference Ranges for Neurofilament Light: A Practical Approach for Clinical Laboratories

    Clinical chemistry

  2. Estimated glomerular filtration rate is associated with NfL in humans (+22% per 1-SD decrease eGFRcr).

    “Specifically, for a 1-SD decrease of eGFRcr, there was a 22% increase in NfL levels in serum.”

    Humansserumn = 1,207

    Impact of kidney function on biomarkers of neurodegeneration, white matter hyperintensities, and cognition in older adults

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  3. Estimated glomerular filtration rate is associated with NfL in humans (adjusted β: -0.23, SE: 0.05, p < 0.001).

    “eGFR was negatively associated with sNfL levels (adjusted β: -0.23, SE: 0.05, p < 0.001).”

    Humansn = 1,782

    Association of frailty and serum neurofilament light chain levels: the mediating role of estimated glomerular filtration rate

    Frontiers in aging neuroscience

  4. NfL is associated with estimated glomerular filtration rate in humans (r = - 0.492; p < 0.0001).

    “consequently, to the estimated glomerular filtration rate (eGFR) (r = - 0.492; p < 0.0001).”

    Humansserumn = 409

    Neurofilament light chain concentration in an aging population

    Aging clinical and experimental research

  5. Estimated glomerular filtration rate is associated with NfL in humans (every 1 ml/min per 1.73 m2 lower eGFR) (0.19 pg/ml higher NfL (95% CI, 0.12 to 0.25)).

    “every 1 ml/min per 1.73 m 2 lower eGFR was associated with 0.19 pg/ml higher NfL (95% confidence interval [CI], 0.12 to 0.25)”

    Reviewevery 1 ml/min per 1.73 m2 lower eGFRblood

    Kidney Function and Blood and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Related Dementias: Systematic Review and Meta-Analysis

    Journal of the American Society of Nephrology : JASN

More on Estimated glomerular filtration rate

Biological age

upin humans2

2 studies
  1. Biological age is associated with NfL in humans (acute phase post-TBI).

    “Age‐stratified analyses revealed increased NfL and GFAP levels in older patients, emphasizing the impact of age on astrocytic activation.”

    Human trialacute phase post-TBIserum

    Assessing biomarkers for predicting Alzheimer's disease in TBI patients: A subanalysis of the double‐blinded, phase III randomized clinical trial with biperiden

    AAIC 2025 abstract

  2. Biological age is associated with NfL in humans.

    “A moderate correlation was found between NfL concentration and age.”

    Humansplasman = 159

    Fluid biomarkers and risk of neurodegenerative disease in retired athletes with multiple concussions: results from the International Concussion and Head Injury Research Foundation Brain health in Retired athletes Study of Ageing and Impact-Related Neurodegenerative Disease (ICHIRF-BRAIN study)

    BMJ open sport & exercise medicine

Late-life depression

upin humans1

1 study
  1. Late-life depression is associated with NfL in humans (late-life depression) (p = 2.51 × 10−2).

    “Biomarker analysis revealed elevated baseline plasma neurofilament light chain (NfL, p = 2.51 × 10−2) and reduced C-X-C Motif Chemokine Ligand 5 (CXCL5, p = 2.83 × 10−2) in the hsGDS group.”

    Human triallate-life depressionplasman = 228

    Exploring blood-based biomarkers in late-life depression: Correlates of psychotherapeutic treatment outcomes

    European psychiatry : the journal of the Association of European Psychiatrists

More on Late-life depression

TBI severity

upin humans1

1 study
  1. NfL is associated with TBI severity in humans (acute phase post-TBI).

    “GFAP and NfL emerged as the most reliable biomarkers, strongly correlating with age, sex, TBI severity and temporal progression post‐injury.”

    Human trialacute phase post-TBIserum

    Assessing biomarkers for predicting Alzheimer's disease in TBI patients: A subanalysis of the double‐blinded, phase III randomized clinical trial with biperiden

    AAIC 2025 abstract

Delirium severity

upin humans1

1 study
  1. NfL is associated with delirium severity in humans (preoperative NfL, per one-standard-deviation increase) (0.32-point increase in CAM-S (95% CI 0.14-0.50)).

    “A one-standard-deviation increase in preoperative NfL was associated with a 0.32-point increase in CAM-S (95% confidence interval [0.14-0.50], p = 0.001).”

    Human trialpreoperative NfL, per one-standard-deviation increasepeak within 3 days after surgeryn = 355

    Nighttime dexmedetomidine modifies the association between neurofilament light chain and delirium severity after major cardiac surgery: a secondary analysis of the MINDDS trial

    GeroScience

Age-related hearing loss

upin humans1

1 study
  1. Age-related hearing loss is associated with NfL in humans.

    “Both biomarkers’ levels were statistically significantly higher in the ARHL group compared to the control group (p < 0.0001).”

    Human trialn = 50

    Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss

    Journal of clinical medicine

More on Age-related hearing loss

All 329

Funding

3 grants since 2022

National Institute on Aging$294KAlzheimer's Drug Discovery Foundation$175KGouvernement du Canada | Canadian Institutes of Health ResearchCA$17.5K

Latest

Dec 2025: 181Jan 2026: 76Feb 2026: 36Mar 2026: 34Apr 2026: 36May 2026: 33Jun 2026: 32Jul 2026: 25Aug 2026: 38Sep 2026: 38Oct 2026: 34Nov 2026: 11574 papers in 12 months
Brain, Behavior, & Immunity - Health

Blood marker may link depressive symptoms to cognitive decline

A blood marker of nerve-fiber damage statistically accounted for 18.05% of the link between depressive symptoms and poorer later cognitive performance.A blood marker of nerve-fiber damage statistically accounted for 18.05% of the link between depressive symptoms and poorer later cognitive performance.

Cohort · 921 peopleMechanisms

See all 1,065 papers on NfL